Perceptive Advisors LLC Harmony Biosciences Holdings, Inc. Transaction History

Perceptive Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $3.35 Million - $4.1 Million	104,936 Added 11.77%	996,306 $32.6 Million
Q2 2023 Aug 14, 2023	BUY	$30.5 - $37.4 $24.1 Million - $29.6 Million	791,370 Added 791.37%	891,370 $31.4 Million
Q1 2023 May 15, 2023	SELL	$30.8 - $53.92 $9.6 Million - $16.8 Million	-311,804 Reduced 75.72%	100,000 $3.27 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $52.15 $13.8 Million - $21.5 Million	411,804 New	411,804 $20.1 Million
Q1 2022 May 16, 2022	SELL	$33.14 - $51.13 $7.93 Million - $12.2 Million	-239,258 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$34.09 - $43.91 $8.59 Million - $11.1 Million	-252,074 Reduced 51.3%	239,258 $10.2 Million
Q2 2021 Aug 16, 2021	BUY	$25.96 - $33.44 $4.66 Million - $6.01 Million	179,659 Added 57.64%	491,332 $13.9 Million
Q1 2021 May 17, 2021	SELL	$27.56 - $40.37 $5.26 Million - $7.71 Million	-190,949 Reduced 37.99%	311,673 $10.3 Million
Q4 2020 Feb 16, 2021	BUY	$31.74 - $51.34 $2.13 Million - $3.45 Million	67,245 Added 15.45%	502,622 $18.2 Million
Q3 2020 Nov 16, 2020	BUY	$30.96 - $44.39 $13.5 Million - $19.3 Million	435,377 New	435,377 $14.8 Million

242

45.2M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.